The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Osimertinib Mesylate API Market Research Report 2025
Synopsis
The global Osimertinib Mesylate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Osimertinib Mesylate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Osimertinib Mesylate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Osimertinib Mesylate API include Teva api, Daicel Chiral Technologies, Transo-Pharm and Alembic Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Osimertinib Mesylate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osimertinib Mesylate API.
Report Scope
The Osimertinib Mesylate API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osimertinib Mesylate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Osimertinib Mesylate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva api
Daicel Chiral Technologies
Transo-Pharm
Alembic Pharmaceuticals
Segment by Type
Purity ≥ 99.0％
Other
Segment by Application
Metastatic Non-small-cell Lung Cancer
Other
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Osimertinib Mesylate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Osimertinib Mesylate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Osimertinib Mesylate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Osimertinib Mesylate API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Osimertinib Mesylate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Osimertinib Mesylate API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Osimertinib Mesylate API include Teva api, Daicel Chiral Technologies, Transo-Pharm and Alembic Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Osimertinib Mesylate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osimertinib Mesylate API.
Report Scope
The Osimertinib Mesylate API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osimertinib Mesylate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Osimertinib Mesylate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva api
Daicel Chiral Technologies
Transo-Pharm
Alembic Pharmaceuticals
Segment by Type
Purity ≥ 99.0％
Other
Segment by Application
Metastatic Non-small-cell Lung Cancer
Other
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Osimertinib Mesylate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Osimertinib Mesylate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Osimertinib Mesylate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Osimertinib Mesylate API Market Overview
1.1 Product Definition
1.2 Osimertinib Mesylate API Segment by Type
1.2.1 Global Osimertinib Mesylate API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 99.0％
1.2.3 Other
1.3 Osimertinib Mesylate API Segment by Application
1.3.1 Global Osimertinib Mesylate API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Metastatic Non-small-cell Lung Cancer
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Osimertinib Mesylate API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Osimertinib Mesylate API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Osimertinib Mesylate API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Osimertinib Mesylate API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Osimertinib Mesylate API Production Market Share by Manufacturers (2019-2024)
2.2 Global Osimertinib Mesylate API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Osimertinib Mesylate API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Osimertinib Mesylate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Osimertinib Mesylate API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Osimertinib Mesylate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Osimertinib Mesylate API, Product Offered and Application
2.8 Global Key Manufacturers of Osimertinib Mesylate API, Date of Enter into This Industry
2.9 Osimertinib Mesylate API Market Competitive Situation and Trends
2.9.1 Osimertinib Mesylate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Osimertinib Mesylate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Osimertinib Mesylate API Production by Region
3.1 Global Osimertinib Mesylate API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Osimertinib Mesylate API Production Value by Region (2019-2030)
3.2.1 Global Osimertinib Mesylate API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Osimertinib Mesylate API by Region (2025-2030)
3.3 Global Osimertinib Mesylate API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Osimertinib Mesylate API Production by Region (2019-2030)
3.4.1 Global Osimertinib Mesylate API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Osimertinib Mesylate API by Region (2025-2030)
3.5 Global Osimertinib Mesylate API Market Price Analysis by Region (2019-2024)
3.6 Global Osimertinib Mesylate API Production and Value, Year-over-Year Growth
3.6.1 North America Osimertinib Mesylate API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Osimertinib Mesylate API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Osimertinib Mesylate API Production Value Estimates and Forecasts (2019-2030)
3.6.4 India Osimertinib Mesylate API Production Value Estimates and Forecasts (2019-2030)
4 Osimertinib Mesylate API Consumption by Region
4.1 Global Osimertinib Mesylate API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Osimertinib Mesylate API Consumption by Region (2019-2030)
4.2.1 Global Osimertinib Mesylate API Consumption by Region (2019-2024)
4.2.2 Global Osimertinib Mesylate API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Osimertinib Mesylate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Osimertinib Mesylate API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Osimertinib Mesylate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Osimertinib Mesylate API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Osimertinib Mesylate API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Osimertinib Mesylate API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Osimertinib Mesylate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Osimertinib Mesylate API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Osimertinib Mesylate API Production by Type (2019-2030)
5.1.1 Global Osimertinib Mesylate API Production by Type (2019-2024)
5.1.2 Global Osimertinib Mesylate API Production by Type (2025-2030)
5.1.3 Global Osimertinib Mesylate API Production Market Share by Type (2019-2030)
5.2 Global Osimertinib Mesylate API Production Value by Type (2019-2030)
5.2.1 Global Osimertinib Mesylate API Production Value by Type (2019-2024)
5.2.2 Global Osimertinib Mesylate API Production Value by Type (2025-2030)
5.2.3 Global Osimertinib Mesylate API Production Value Market Share by Type (2019-2030)
5.3 Global Osimertinib Mesylate API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Osimertinib Mesylate API Production by Application (2019-2030)
6.1.1 Global Osimertinib Mesylate API Production by Application (2019-2024)
6.1.2 Global Osimertinib Mesylate API Production by Application (2025-2030)
6.1.3 Global Osimertinib Mesylate API Production Market Share by Application (2019-2030)
6.2 Global Osimertinib Mesylate API Production Value by Application (2019-2030)
6.2.1 Global Osimertinib Mesylate API Production Value by Application (2019-2024)
6.2.2 Global Osimertinib Mesylate API Production Value by Application (2025-2030)
6.2.3 Global Osimertinib Mesylate API Production Value Market Share by Application (2019-2030)
6.3 Global Osimertinib Mesylate API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Teva api
7.1.1 Teva api Osimertinib Mesylate API Corporation Information
7.1.2 Teva api Osimertinib Mesylate API Product Portfolio
7.1.3 Teva api Osimertinib Mesylate API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Teva api Main Business and Markets Served
7.1.5 Teva api Recent Developments/Updates
7.2 Daicel Chiral Technologies
7.2.1 Daicel Chiral Technologies Osimertinib Mesylate API Corporation Information
7.2.2 Daicel Chiral Technologies Osimertinib Mesylate API Product Portfolio
7.2.3 Daicel Chiral Technologies Osimertinib Mesylate API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Daicel Chiral Technologies Main Business and Markets Served
7.2.5 Daicel Chiral Technologies Recent Developments/Updates
7.3 Transo-Pharm
7.3.1 Transo-Pharm Osimertinib Mesylate API Corporation Information
7.3.2 Transo-Pharm Osimertinib Mesylate API Product Portfolio
7.3.3 Transo-Pharm Osimertinib Mesylate API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Transo-Pharm Main Business and Markets Served
7.3.5 Transo-Pharm Recent Developments/Updates
7.4 Alembic Pharmaceuticals
7.4.1 Alembic Pharmaceuticals Osimertinib Mesylate API Corporation Information
7.4.2 Alembic Pharmaceuticals Osimertinib Mesylate API Product Portfolio
7.4.3 Alembic Pharmaceuticals Osimertinib Mesylate API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Alembic Pharmaceuticals Main Business and Markets Served
7.4.5 Alembic Pharmaceuticals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Osimertinib Mesylate API Industry Chain Analysis
8.2 Osimertinib Mesylate API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Osimertinib Mesylate API Production Mode & Process
8.4 Osimertinib Mesylate API Sales and Marketing
8.4.1 Osimertinib Mesylate API Sales Channels
8.4.2 Osimertinib Mesylate API Distributors
8.5 Osimertinib Mesylate API Customers
9 Osimertinib Mesylate API Market Dynamics
9.1 Osimertinib Mesylate API Industry Trends
9.2 Osimertinib Mesylate API Market Drivers
9.3 Osimertinib Mesylate API Market Challenges
9.4 Osimertinib Mesylate API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Osimertinib Mesylate API Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Osimertinib Mesylate API Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Osimertinib Mesylate API Production Capacity (Ton) by Manufacturers in 2023
Table 4. Global Osimertinib Mesylate API Production by Manufacturers (2019-2024) & (Ton)
Table 5. Global Osimertinib Mesylate API Production Market Share by Manufacturers (2019-2024)
Table 6. Global Osimertinib Mesylate API Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Osimertinib Mesylate API Production Value Share by Manufacturers (2019-2024)
Table 8. Global Osimertinib Mesylate API Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osimertinib Mesylate API as of 2023)
Table 10. Global Market Osimertinib Mesylate API Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Osimertinib Mesylate API Production Sites and Area Served
Table 12. Manufacturers Osimertinib Mesylate API Product Types
Table 13. Global Osimertinib Mesylate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Osimertinib Mesylate API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Osimertinib Mesylate API Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Osimertinib Mesylate API Production Value Market Share by Region (2019-2024)
Table 18. Global Osimertinib Mesylate API Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Osimertinib Mesylate API Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Osimertinib Mesylate API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Table 21. Global Osimertinib Mesylate API Production (Ton) by Region (2019-2024)
Table 22. Global Osimertinib Mesylate API Production Market Share by Region (2019-2024)
Table 23. Global Osimertinib Mesylate API Production (Ton) Forecast by Region (2025-2030)
Table 24. Global Osimertinib Mesylate API Production Market Share Forecast by Region (2025-2030)
Table 25. Global Osimertinib Mesylate API Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Osimertinib Mesylate API Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Osimertinib Mesylate API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 28. Global Osimertinib Mesylate API Consumption by Region (2019-2024) & (Ton)
Table 29. Global Osimertinib Mesylate API Consumption Market Share by Region (2019-2024)
Table 30. Global Osimertinib Mesylate API Forecasted Consumption by Region (2025-2030) & (Ton)
Table 31. Global Osimertinib Mesylate API Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Osimertinib Mesylate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 33. North America Osimertinib Mesylate API Consumption by Country (2019-2024) & (Ton)
Table 34. North America Osimertinib Mesylate API Consumption by Country (2025-2030) & (Ton)
Table 35. Europe Osimertinib Mesylate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 36. Europe Osimertinib Mesylate API Consumption by Country (2019-2024) & (Ton)
Table 37. Europe Osimertinib Mesylate API Consumption by Country (2025-2030) & (Ton)
Table 38. Asia Pacific Osimertinib Mesylate API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Ton)
Table 39. Asia Pacific Osimertinib Mesylate API Consumption by Region (2019-2024) & (Ton)
Table 40. Asia Pacific Osimertinib Mesylate API Consumption by Region (2025-2030) & (Ton)
Table 41. Latin America, Middle East & Africa Osimertinib Mesylate API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Ton)
Table 42. Latin America, Middle East & Africa Osimertinib Mesylate API Consumption by Country (2019-2024) & (Ton)
Table 43. Latin America, Middle East & Africa Osimertinib Mesylate API Consumption by Country (2025-2030) & (Ton)
Table 44. Global Osimertinib Mesylate API Production (Ton) by Type (2019-2024)
Table 45. Global Osimertinib Mesylate API Production (Ton) by Type (2025-2030)
Table 46. Global Osimertinib Mesylate API Production Market Share by Type (2019-2024)
Table 47. Global Osimertinib Mesylate API Production Market Share by Type (2025-2030)
Table 48. Global Osimertinib Mesylate API Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Osimertinib Mesylate API Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Osimertinib Mesylate API Production Value Share by Type (2019-2024)
Table 51. Global Osimertinib Mesylate API Production Value Share by Type (2025-2030)
Table 52. Global Osimertinib Mesylate API Price (US$/Ton) by Type (2019-2024)
Table 53. Global Osimertinib Mesylate API Price (US$/Ton) by Type (2025-2030)
Table 54. Global Osimertinib Mesylate API Production (Ton) by Application (2019-2024)
Table 55. Global Osimertinib Mesylate API Production (Ton) by Application (2025-2030)
Table 56. Global Osimertinib Mesylate API Production Market Share by Application (2019-2024)
Table 57. Global Osimertinib Mesylate API Production Market Share by Application (2025-2030)
Table 58. Global Osimertinib Mesylate API Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Osimertinib Mesylate API Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Osimertinib Mesylate API Production Value Share by Application (2019-2024)
Table 61. Global Osimertinib Mesylate API Production Value Share by Application (2025-2030)
Table 62. Global Osimertinib Mesylate API Price (US$/Ton) by Application (2019-2024)
Table 63. Global Osimertinib Mesylate API Price (US$/Ton) by Application (2025-2030)
Table 64. Teva api Osimertinib Mesylate API Corporation Information
Table 65. Teva api Specification and Application
Table 66. Teva api Osimertinib Mesylate API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Teva api Main Business and Markets Served
Table 68. Teva api Recent Developments/Updates
Table 69. Daicel Chiral Technologies Osimertinib Mesylate API Corporation Information
Table 70. Daicel Chiral Technologies Specification and Application
Table 71. Daicel Chiral Technologies Osimertinib Mesylate API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Daicel Chiral Technologies Main Business and Markets Served
Table 73. Daicel Chiral Technologies Recent Developments/Updates
Table 74. Transo-Pharm Osimertinib Mesylate API Corporation Information
Table 75. Transo-Pharm Specification and Application
Table 76. Transo-Pharm Osimertinib Mesylate API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Transo-Pharm Main Business and Markets Served
Table 78. Transo-Pharm Recent Developments/Updates
Table 79. Alembic Pharmaceuticals Osimertinib Mesylate API Corporation Information
Table 80. Alembic Pharmaceuticals Specification and Application
Table 81. Alembic Pharmaceuticals Osimertinib Mesylate API Production (Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Alembic Pharmaceuticals Main Business and Markets Served
Table 83. Alembic Pharmaceuticals Recent Developments/Updates
Table 84. Key Raw Materials Lists
Table 85. Raw Materials Key Suppliers Lists
Table 86. Osimertinib Mesylate API Distributors List
Table 87. Osimertinib Mesylate API Customers List
Table 88. Osimertinib Mesylate API Market Trends
Table 89. Osimertinib Mesylate API Market Drivers
Table 90. Osimertinib Mesylate API Market Challenges
Table 91. Osimertinib Mesylate API Market Restraints
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Osimertinib Mesylate API
Figure 2. Global Osimertinib Mesylate API Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Osimertinib Mesylate API Market Share by Type: 2023 VS 2030
Figure 4. Purity ≥ 99.0％ Product Picture
Figure 5. Other Product Picture
Figure 6. Global Osimertinib Mesylate API Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Osimertinib Mesylate API Market Share by Application: 2023 VS 2030
Figure 8. Metastatic Non-small-cell Lung Cancer
Figure 9. Other
Figure 10. Global Osimertinib Mesylate API Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Osimertinib Mesylate API Production Value (US$ Million) & (2019-2030)
Figure 12. Global Osimertinib Mesylate API Production Capacity (Ton) & (2019-2030)
Figure 13. Global Osimertinib Mesylate API Production (Ton) & (2019-2030)
Figure 14. Global Osimertinib Mesylate API Average Price (US$/Ton) & (2019-2030)
Figure 15. Osimertinib Mesylate API Report Years Considered
Figure 16. Osimertinib Mesylate API Production Share by Manufacturers in 2023
Figure 17. Osimertinib Mesylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. The Global 5 and 10 Largest Players: Market Share by Osimertinib Mesylate API Revenue in 2023
Figure 19. Global Osimertinib Mesylate API Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 20. Global Osimertinib Mesylate API Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Osimertinib Mesylate API Production Comparison by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 22. Global Osimertinib Mesylate API Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Osimertinib Mesylate API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Osimertinib Mesylate API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Osimertinib Mesylate API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. India Osimertinib Mesylate API Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Osimertinib Mesylate API Consumption by Region: 2019 VS 2023 VS 2030 (Ton)
Figure 28. Global Osimertinib Mesylate API Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 30. North America Osimertinib Mesylate API Consumption Market Share by Country (2019-2030)
Figure 31. Canada Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 32. U.S. Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 33. Europe Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 34. Europe Osimertinib Mesylate API Consumption Market Share by Country (2019-2030)
Figure 35. Germany Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 36. France Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 37. U.K. Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 38. Italy Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 39. Russia Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 40. Asia Pacific Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 41. Asia Pacific Osimertinib Mesylate API Consumption Market Share by Regions (2019-2030)
Figure 42. China Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 43. Japan Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 44. South Korea Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 45. China Taiwan Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 46. Southeast Asia Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 47. India Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 48. Latin America, Middle East & Africa Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 49. Latin America, Middle East & Africa Osimertinib Mesylate API Consumption Market Share by Country (2019-2030)
Figure 50. Mexico Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 51. Brazil Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 52. Turkey Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 53. GCC Countries Osimertinib Mesylate API Consumption and Growth Rate (2019-2024) & (Ton)
Figure 54. Global Production Market Share of Osimertinib Mesylate API by Type (2019-2030)
Figure 55. Global Production Value Market Share of Osimertinib Mesylate API by Type (2019-2030)
Figure 56. Global Osimertinib Mesylate API Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Production Market Share of Osimertinib Mesylate API by Application (2019-2030)
Figure 58. Global Production Value Market Share of Osimertinib Mesylate API by Application (2019-2030)
Figure 59. Global Osimertinib Mesylate API Price (US$/Ton) by Application (2019-2030)
Figure 60. Osimertinib Mesylate API Value Chain
Figure 61. Osimertinib Mesylate API Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
